CA2560507A1 - Composition and method for preparing biocompatible surfaces - Google Patents
Composition and method for preparing biocompatible surfaces Download PDFInfo
- Publication number
- CA2560507A1 CA2560507A1 CA002560507A CA2560507A CA2560507A1 CA 2560507 A1 CA2560507 A1 CA 2560507A1 CA 002560507 A CA002560507 A CA 002560507A CA 2560507 A CA2560507 A CA 2560507A CA 2560507 A1 CA2560507 A1 CA 2560507A1
- Authority
- CA
- Canada
- Prior art keywords
- medical article
- coated layer
- bioactive agent
- photoreactive groups
- heparin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
- A61L2300/608—Coatings having two or more layers
Abstract
The invention provides methods and compositions for providing biocompatible surfaces to medical articles. In particular the invention provides biocompatible coatings with heparin activity. In some aspects, the biocompatible coatings of the invention are able to release a bioactive agent.
The coatings can be formed using biostable or biodegradable polymeric material and photoreactive groups. The invention also provides methods for improving the quality of bioactive agent-containing coatings by performing pre-irradiation of biocompatible coating compositions.
The coatings can be formed using biostable or biodegradable polymeric material and photoreactive groups. The invention also provides methods for improving the quality of bioactive agent-containing coatings by performing pre-irradiation of biocompatible coating compositions.
Claims (22)
1. A medical article having a bioactive agent-releasing coating having heparin activity, the coating comprising:
(a) a first coated layer comprising a bioactive agent; and (b) a second coated layer formed from a second coating composition comprising heparin, photoreactive groups, and a polymeric material, wherein the second coating composition is irradiated prior to being disposed to form the second coated layer.
(a) a first coated layer comprising a bioactive agent; and (b) a second coated layer formed from a second coating composition comprising heparin, photoreactive groups, and a polymeric material, wherein the second coating composition is irradiated prior to being disposed to form the second coated layer.
2. The medical article of claim 1 wherein the first coated layer comprises a hydrophobic polymer.
3. The medical article of claim 2 wherein the hydrophobic polymer of the first coated layer is selected from the group of poly(alkyl(meth)acrylates).
4. The medical article of claim 3 wherein the hydrophobic polymer of the first coated layer is poly(butyl(meth)acrylate).
5. The medical article of claim 2 wherein the first coated layer further comprises a polymer that is different than, but can be blended with, the hydrophobic polymer.
6. The medical article of claim 5 wherein the first coated layer further comprises poly(ethylene-co-vinyl acetate).
7. The medical article of claim 1 wherein the polymeric material of the second coated layer comprises a hydrophobic polymer.
8. The medical article of claim 7 wherein the hydrophobic polymer of the first coated layer and the hydrophobic polymer of the second coated layer are the same.
9. The medical article of claim 1 wherein the bioactive agent is selected from the group consisting of anti-proliferative agents, an anti-mitotics, and antibiotics.
10. The medical article of claim 9 wherein the bioactive agent is selected from rapamycin and analogs thereof.
11. The medical article of claim 1 wherein the photoreactive groups are pendent from heparin.
12. The medical article of claim 1 wherein the second coated layer further comprises a component selected from the group consisting of polyvinylpyrrolidone, polyethylene glycol, polyethylene glycol sulfonates, fatty quaternary amines, fatty sulfonates, fatty acids, dextran, dextrin, and cyclodextrin.
13. The medical article of claim 12 wherein the second coated layer comprises polyvinylpyrrolidone.
14. The medical article of claim 12 wherein photoreactive groups are pendent from a component selected from the group consisting of polyvinylpyrrolidone, polyethylene glycol, polyethylene glycol sulfonates, fatty quaternary amines, fatty sulfonates, fatty acids, dextran, dextrin, and cyclodextrin.
15. The medical article of claim 14 wherein the photoreactive groups are pendent from polyvinylpyrrolidone.
16. The medical article of claim 15 wherein the photoreactive groups are pendent from both heparin and poly(vinylpyrrolidone).
17. The medical article of claim 1 being an intraluminal prosthesis.
18. The medical article of claim 17 being a stent.
19. The medical article of claim 1 comprising a third coated layer comprising a polymeric material, wherein the third coated layer is either between the first coated layer and the surface, or between the first coated layer and the second coated layer.
20. A method for preparing a medical article having a bioactive agent-releasing coating with heparin activity, comprising the steps of:
(a) providing a medical article having a first coated layer comprising a bioactive agent; and (b) irradiating a composition comprising heparin, photoreactive groups, and polymeric material to activate the photoreactive groups;
(c) after step (b), disposing the irradiated composition on the first coated layer.
(a) providing a medical article having a first coated layer comprising a bioactive agent; and (b) irradiating a composition comprising heparin, photoreactive groups, and polymeric material to activate the photoreactive groups;
(c) after step (b), disposing the irradiated composition on the first coated layer.
21. A medical article having a bioactive agent-releasing coating having heparin activity of 10 mU/cm2 or greater, the coating comprising:
(a) biostable or biodegradable polymer;
(b) bioactive agent;
(c) heparin, and (d) photoreactive groups, wherein the photoreactive groups are activated prior to being placed in contact with the medical article.
(a) biostable or biodegradable polymer;
(b) bioactive agent;
(c) heparin, and (d) photoreactive groups, wherein the photoreactive groups are activated prior to being placed in contact with the medical article.
22. A medical article having a bioactive agent-releasing coating comprising:
(a) hydrophobic polymer (b) bioactive agent;
(c) heparin;
(d) photoreactive groups; and (e) a component selected from the group consisting of polyvinylpyrrolidone, polyethylene glycol, polyethylene glycol sulfonates, fatty quaternary amines, fatty sulfonates, fatty acids, dextran, dextrin, and cyclodextrin..
(a) hydrophobic polymer (b) bioactive agent;
(c) heparin;
(d) photoreactive groups; and (e) a component selected from the group consisting of polyvinylpyrrolidone, polyethylene glycol, polyethylene glycol sulfonates, fatty quaternary amines, fatty sulfonates, fatty acids, dextran, dextrin, and cyclodextrin..
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55663404P | 2004-03-26 | 2004-03-26 | |
US60/556,634 | 2004-03-26 | ||
US56802104P | 2004-05-03 | 2004-05-03 | |
US56791504P | 2004-05-03 | 2004-05-03 | |
US60/568,021 | 2004-05-03 | ||
US60/567,915 | 2004-05-03 | ||
US64060204P | 2004-12-31 | 2004-12-31 | |
US60/640,602 | 2004-12-31 | ||
PCT/US2005/009908 WO2005097223A1 (en) | 2004-03-26 | 2005-03-25 | Composition and method for preparing biocompatible surfaces |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2560507A1 true CA2560507A1 (en) | 2005-10-20 |
CA2560507C CA2560507C (en) | 2011-08-16 |
Family
ID=34963852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2560507A Expired - Fee Related CA2560507C (en) | 2004-03-26 | 2005-03-25 | Composition and method for preparing biocompatible surfaces |
Country Status (5)
Country | Link |
---|---|
US (2) | US7550444B2 (en) |
EP (2) | EP1732619A1 (en) |
JP (1) | JP2007530169A (en) |
CA (1) | CA2560507C (en) |
WO (1) | WO2005097223A1 (en) |
Families Citing this family (118)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7611533B2 (en) | 1995-06-07 | 2009-11-03 | Cook Incorporated | Coated implantable medical device |
US7666462B2 (en) * | 2001-05-11 | 2010-02-23 | Exogenesis Corporation | Method of controlling a drug release rate |
US7923055B2 (en) | 2001-05-11 | 2011-04-12 | Exogenesis Corporation | Method of manufacturing a drug delivery system |
US8889169B2 (en) * | 2001-05-11 | 2014-11-18 | Exogenesis Corporation | Drug delivery system and method of manufacturing thereof |
US8313760B2 (en) | 2002-05-24 | 2012-11-20 | Angiotech International Ag | Compositions and methods for coating medical implants |
EP1509256B1 (en) | 2002-05-24 | 2009-07-22 | Angiotech International Ag | Compositions and methods for coating medical implants |
AU2003298626A1 (en) * | 2002-11-12 | 2004-06-03 | The Polymer Technology Group Incorporated | Control of polymer surface molecular architecture via amphipathic endgroups |
WO2005097222A1 (en) * | 2004-03-26 | 2005-10-20 | Surmodics, Inc. | Process and systems for biocompatible surfaces |
US8003122B2 (en) * | 2004-03-31 | 2011-08-23 | Cordis Corporation | Device for local and/or regional delivery employing liquid formulations of therapeutic agents |
US7772393B2 (en) | 2005-06-13 | 2010-08-10 | Innovative Surface Technologies, Inc. | Photochemical crosslinkers for polymer coatings and substrate tie-layer |
KR101406415B1 (en) | 2005-07-15 | 2014-06-19 | 미셀 테크놀로지즈, 인코포레이티드 | Polymer coatings containing drug powder of controlled morphology |
WO2007011708A2 (en) | 2005-07-15 | 2007-01-25 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
EP1904118B1 (en) * | 2005-07-20 | 2018-01-17 | Surmodics, Inc. | Polymeric coatings and methods for cell attachment |
US20090118816A1 (en) * | 2005-09-06 | 2009-05-07 | Light Sciences Oncology, Inc. | Implantable Device for Therapeutic Treatment Within a Body Lumen |
WO2007056561A2 (en) * | 2005-11-09 | 2007-05-18 | Liquidia Technologies, Inc. | Medical device, materials, and methods |
US20070160743A1 (en) * | 2006-01-09 | 2007-07-12 | Babitt John L | Method for coating biocompatible material on a substrate |
US20070178137A1 (en) * | 2006-02-01 | 2007-08-02 | Toby Freyman | Local control of inflammation |
US8636753B2 (en) * | 2006-02-08 | 2014-01-28 | Tyrx, Inc. | Temporarily stiffened mesh prostheses |
US8349349B2 (en) * | 2006-02-28 | 2013-01-08 | Covidien Lp | Tissue adhesives and sealants and method for their use |
US8835513B2 (en) | 2006-02-28 | 2014-09-16 | Covidien Lp | Drug delivery devices |
EP3050578B1 (en) * | 2006-02-28 | 2020-08-05 | Covidien LP | Tissue adhesive and sealants and methods for their use |
EP1832301A3 (en) * | 2006-03-08 | 2007-12-05 | Sahajanand Medical Technologies PVT. ltd | Coatings for implantable medical devices |
WO2007127363A2 (en) | 2006-04-26 | 2007-11-08 | Micell Technologies, Inc. | Coatings containing multiple drugs |
US8703167B2 (en) * | 2006-06-05 | 2014-04-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug |
AU2007273119A1 (en) * | 2006-07-07 | 2008-01-17 | Surmodics, Inc. | Implantable medical articles having pro-healing coatings |
US20080063627A1 (en) * | 2006-09-12 | 2008-03-13 | Surmodics, Inc. | Tissue graft materials containing biocompatible agent and methods of making and using same |
US20080075779A1 (en) * | 2006-09-27 | 2008-03-27 | Chappa Ralph A | Additives And Methods For Enhancing Active Agent Elution Kinetics |
CA2667228C (en) | 2006-10-23 | 2015-07-14 | Micell Technologies, Inc. | Holder for electrically charging a substrate during coating |
US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
WO2008086369A1 (en) | 2007-01-08 | 2008-07-17 | Micell Technologies, Inc. | Stents having biodegradable layers |
US20090281059A1 (en) | 2007-02-21 | 2009-11-12 | Robert Falotico | Coating for a medical device having an anti-thrombotic conjugate |
US20080200421A1 (en) | 2007-02-21 | 2008-08-21 | Zhao Jonathon Z | Coating for a medical device having an anti-thrombotic conjugate |
US20100069957A1 (en) * | 2007-04-25 | 2010-03-18 | Ferass Abuzaina | Coated Filaments |
US8383156B2 (en) | 2007-04-30 | 2013-02-26 | Cordis Corporation | Coating for a medical device having an anti-thrombotic conjugate |
WO2008148013A1 (en) | 2007-05-25 | 2008-12-04 | Micell Technologies, Inc. | Polymer films for medical device coating |
US8133553B2 (en) | 2007-06-18 | 2012-03-13 | Zimmer, Inc. | Process for forming a ceramic layer |
US8309521B2 (en) | 2007-06-19 | 2012-11-13 | Zimmer, Inc. | Spacer with a coating thereon for use with an implant device |
US20090018646A1 (en) | 2007-07-10 | 2009-01-15 | Zhao Jonathon Z | Coating Employing an Anti-Thrombotic Conjugate |
US8608049B2 (en) | 2007-10-10 | 2013-12-17 | Zimmer, Inc. | Method for bonding a tantalum structure to a cobalt-alloy substrate |
WO2009051780A1 (en) * | 2007-10-19 | 2009-04-23 | Micell Technologies, Inc. | Drug coated stents |
HUE039362T2 (en) | 2008-01-11 | 2018-12-28 | Ucb Biopharma Sprl | Systems for administering medication for rheumatoid arthritis patients |
US8951545B2 (en) * | 2008-03-28 | 2015-02-10 | Surmodics, Inc. | Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery |
US8409601B2 (en) | 2008-03-31 | 2013-04-02 | Cordis Corporation | Rapamycin coated expandable devices |
US8420110B2 (en) * | 2008-03-31 | 2013-04-16 | Cordis Corporation | Drug coated expandable devices |
JP5608160B2 (en) | 2008-04-17 | 2014-10-15 | ミセル テクノロジーズ、インコーポレイテッド | Stent with bioabsorbable layer |
US8496954B2 (en) * | 2008-04-18 | 2013-07-30 | Surmodics, Inc. | Coating systems for the controlled delivery of hydrophilic bioactive agents |
ES2500616T3 (en) * | 2008-05-09 | 2014-09-30 | Evonik Corporation | Biocompatible and biodegradable elastomeric polymers |
CA2946195A1 (en) | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug delivery medical device |
US20100036482A1 (en) * | 2008-08-07 | 2010-02-11 | Exogenesis Corporation | Drug delivery system and method of manufacturing thereof |
EP2326356B1 (en) | 2008-08-07 | 2017-10-11 | Exogenesis Corporation | Medical device for bone implant and method for producing such a device |
WO2010028104A1 (en) * | 2008-09-05 | 2010-03-11 | Innovative Surface Technologies, Inc. | Photoactivatable crosslinker compositions for surface modification |
WO2010042600A2 (en) * | 2008-10-08 | 2010-04-15 | The Uab Research Foundation | Photo-activatable therapeutic agents and methods of using |
US8834913B2 (en) | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
CN104178926B (en) | 2009-01-16 | 2018-02-09 | Zeus工业品公司 | Electrospun is carried out to PTFE using heavy viscous material |
US20130268062A1 (en) | 2012-04-05 | 2013-10-10 | Zeus Industrial Products, Inc. | Composite prosthetic devices |
US20100198278A1 (en) * | 2009-02-02 | 2010-08-05 | Medtronic, Inc. | Composite antimicrobial accessory including a membrane layer and a porous layer |
US8535477B2 (en) | 2009-02-21 | 2013-09-17 | Sofradim Production | Medical devices incorporating functional adhesives |
AU2010215192B2 (en) | 2009-02-21 | 2015-04-30 | Sofradim Production | Amphiphilic compounds and self-assembling compositions made therefrom |
CA2753171A1 (en) | 2009-02-21 | 2010-08-26 | Sofradim Production | Crosslinked fibers and method of making same using uv radiation |
AU2010215203B2 (en) | 2009-02-21 | 2015-07-16 | Covidien Lp | Medical devices with an activated coating |
CA2753189A1 (en) | 2009-02-21 | 2010-08-26 | Nadya Belcheva | Medical devices having activated surfaces |
US9555154B2 (en) | 2009-02-21 | 2017-01-31 | Covidien Lp | Medical devices having activated surfaces |
EP2398584A2 (en) | 2009-02-21 | 2011-12-28 | Sofradim Production | Apparatus and method of reaching polymers by exposure to uv radiation to produce injectable medical devices |
US9039979B2 (en) | 2009-02-21 | 2015-05-26 | Sofradim Production | Apparatus and method of reacting polymers passing through metal ion chelated resin matrix to produce injectable medical devices |
EP2398941B1 (en) | 2009-02-21 | 2016-07-13 | Sofradim Production | Crosslinked fibers and method of making same by extrusion |
WO2010095052A2 (en) * | 2009-02-21 | 2010-08-26 | Sofradim Production | Compounds and medical devices activated with solvophobic linkers |
US8691983B2 (en) | 2009-03-03 | 2014-04-08 | Innovative Surface Technologies, Inc. | Brush polymer coating by in situ polymerization from photoreactive surface |
EP2413847A4 (en) | 2009-04-01 | 2013-11-27 | Micell Technologies Inc | Coated stents |
WO2010118435A2 (en) | 2009-04-10 | 2010-10-14 | Tufts Medical Center, Inc. | Par-1 activation by metalloproteinase-1 (mmp-1) |
EP3366326A1 (en) | 2009-04-17 | 2018-08-29 | Micell Technologies, Inc. | Stents having controlled elution |
US8858983B2 (en) * | 2009-04-30 | 2014-10-14 | Medtronic, Inc. | Antioxidants and antimicrobial accessories including antioxidants |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
EP2453834A4 (en) | 2009-07-16 | 2014-04-16 | Micell Technologies Inc | Drug delivery medical device |
EP2461766A4 (en) | 2009-08-07 | 2013-09-18 | Zeus Ind Products Inc | Prosthetic device including electrostatically spun fibrous layer and method for making the same |
US8529492B2 (en) | 2009-12-23 | 2013-09-10 | Trascend Medical, Inc. | Drug delivery devices and methods |
US11369498B2 (en) | 2010-02-02 | 2022-06-28 | MT Acquisition Holdings LLC | Stent and stent delivery system with improved deliverability |
US8795762B2 (en) | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
CA2797110C (en) | 2010-04-22 | 2020-07-21 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
US20110270021A1 (en) * | 2010-04-30 | 2011-11-03 | Allergan, Inc. | Electronically enhanced access port for a fluid filled implant |
WO2012006147A1 (en) | 2010-06-29 | 2012-01-12 | Tyco Healthcare Group Lp | Microwave-powered reactor and method for in situ forming implants |
WO2012001532A2 (en) | 2010-07-01 | 2012-01-05 | Sofradim Production | Medical device with predefined activated cellular integration |
CA2805631C (en) | 2010-07-16 | 2018-07-31 | Micell Technologies, Inc. | Drug delivery medical device |
US8716204B2 (en) | 2010-07-27 | 2014-05-06 | Zimmer, Inc. | Synthetic synovial fluid compositions and methods for making the same |
US9861814B2 (en) * | 2010-12-23 | 2018-01-09 | Medtronic, Inc. | Medical electrical lead having biological surface and methods of making and using same |
US8911427B2 (en) | 2010-12-28 | 2014-12-16 | Medtronic, Inc. | Therapeutic agent reservoir delivery system |
WO2012092566A1 (en) | 2010-12-30 | 2012-07-05 | Surmodics, Inc. | Cell attachment coatings and methods |
EP2667829B1 (en) | 2011-01-28 | 2021-09-22 | Merit Medical Systems, Inc. | Electrospun ptfe coated stent and method of use |
US10464100B2 (en) | 2011-05-31 | 2019-11-05 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
US10117972B2 (en) | 2011-07-15 | 2018-11-06 | Micell Technologies, Inc. | Drug delivery medical device |
US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
KR102037543B1 (en) | 2012-01-16 | 2019-10-28 | 메리트 메디컬 시스템즈, 인크. | Rotational spun material covered medical appliances and methods of manufacture |
EP3012301B1 (en) | 2012-01-18 | 2023-08-16 | SurModics, Inc. | Lubricious medical device coating with low particulates |
US9572580B2 (en) | 2012-03-16 | 2017-02-21 | Covidien Lp | Closure tape dispenser |
US9161756B2 (en) | 2012-03-16 | 2015-10-20 | Covidien Lp | Closure tape dispenser |
US9631190B2 (en) | 2012-06-29 | 2017-04-25 | Surmodics, Inc. | Cell attachment coatings and methods using phosphorous-containing photoreagent |
US11541154B2 (en) | 2012-09-19 | 2023-01-03 | Merit Medical Systems, Inc. | Electrospun material covered medical appliances and methods of manufacture |
US9198999B2 (en) * | 2012-09-21 | 2015-12-01 | Merit Medical Systems, Inc. | Drug-eluting rotational spun coatings and methods of use |
JP6330024B2 (en) | 2013-03-12 | 2018-05-23 | マイセル・テクノロジーズ,インコーポレイテッド | Bioabsorbable biomedical implant |
CN104884694B (en) | 2013-03-13 | 2018-09-11 | 麦瑞通医疗设备有限公司 | The fibrous material of successive sedimentation and associated device and method |
EP2967929B1 (en) | 2013-03-13 | 2017-11-29 | Merit Medical Systems, Inc. | Methods, systems, and apparatuses for manufacturing rotational spun appliances |
JP2016519965A (en) | 2013-05-15 | 2016-07-11 | マイセル・テクノロジーズ,インコーポレイテッド | Bioabsorbable biomedical implant |
US9775928B2 (en) | 2013-06-18 | 2017-10-03 | Covidien Lp | Adhesive barbed filament |
CZ2014451A3 (en) | 2014-06-30 | 2016-01-13 | Contipro Pharma A.S. | Antitumor composition based on hyaluronic acid and inorganic nanoparticles, process of its preparation and use |
US10576456B2 (en) * | 2014-06-30 | 2020-03-03 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Systems and methods of preparing stabilized lipid assemblies |
US10124088B2 (en) * | 2014-09-29 | 2018-11-13 | Surmodics, Inc. | Lubricious medical device elements |
US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
US10028852B2 (en) | 2015-02-26 | 2018-07-24 | Merit Medical Systems, Inc. | Layered medical appliances and methods |
CZ309295B6 (en) | 2015-03-09 | 2022-08-10 | Contipro A.S. | Self-supporting, biodegradable film based on hydrophobized hyaluronic acid, method of its preparation and use |
CZ2015398A3 (en) | 2015-06-15 | 2017-02-08 | Contipro A.S. | A method of crosslinking polysaccharides by using photolabile protecting groups |
CZ306662B6 (en) | 2015-06-26 | 2017-04-26 | Contipro A.S. | Sulphated polysaccharides derivatives, the method of their preparation, the method of their modification and the use |
US11174447B2 (en) | 2015-12-29 | 2021-11-16 | Surmodics, Inc. | Lubricious coatings with surface salt groups |
US10342898B2 (en) | 2015-12-29 | 2019-07-09 | Surmodics, Inc. | Lubricious coatings with surface salt groups |
CZ308106B6 (en) | 2016-06-27 | 2020-01-08 | Contipro A.S. | Unsaturated derivatives of polysaccharides, preparing and using them |
US11123459B2 (en) | 2016-12-16 | 2021-09-21 | Surmodics, Inc. | Hydrophobic active agent particle coatings and methods for treatment |
US11357542B2 (en) | 2019-06-21 | 2022-06-14 | Covidien Lp | Valve assembly and retainer for surgical access assembly |
CN112843343A (en) * | 2021-01-18 | 2021-05-28 | 成都鼎峰前瞻科技有限公司 | Blood contact type functional material, preparation method and application thereof |
CN114808469B (en) * | 2021-12-30 | 2023-06-06 | 南京大学 | Method for fixing heparin on polyester fabric artificial blood vessel by ultraviolet curing method and application |
WO2023172686A1 (en) * | 2022-03-09 | 2023-09-14 | Surmodics Coatings, LLC | Thromboresistant coatings, coated devices, and methods |
Family Cites Families (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5002582A (en) | 1982-09-29 | 1991-03-26 | Bio-Metric Systems, Inc. | Preparation of polymeric surfaces via covalently attaching polymers |
US4979959A (en) * | 1986-10-17 | 1990-12-25 | Bio-Metric Systems, Inc. | Biocompatible coating for solid surfaces |
US6387379B1 (en) | 1987-04-10 | 2002-05-14 | University Of Florida | Biofunctional surface modified ocular implants, surgical instruments, medical devices, prostheses, contact lenses and the like |
JPH0636509B2 (en) * | 1990-06-22 | 1994-05-11 | 日本航空電子工業株式会社 | Optical bus transmission system |
US5252701A (en) | 1990-07-06 | 1993-10-12 | American Cyanamid Company | Segmented absorbable copolymer |
US5163952A (en) * | 1990-09-14 | 1992-11-17 | Michael Froix | Expandable polymeric stent with memory and delivery apparatus and method |
US5443907A (en) * | 1991-06-18 | 1995-08-22 | Scimed Life Systems, Inc. | Coating for medical insertion guides |
US5500013A (en) * | 1991-10-04 | 1996-03-19 | Scimed Life Systems, Inc. | Biodegradable drug delivery vascular stent |
JP3093375B2 (en) * | 1991-11-01 | 2000-10-03 | 株式会社東海メディカルプロダクツ | Immobilization method of antithrombotic substance |
EP0585436B1 (en) * | 1992-02-13 | 2000-05-03 | SurModics, Inc. | Immobilization of chemical species in crosslinked matrices |
AU670937B2 (en) | 1992-04-28 | 1996-08-08 | Wyeth | Method of treating hyperproliferative vascular disease |
US5414075A (en) | 1992-11-06 | 1995-05-09 | Bsi Corporation | Restrained multifunctional reagent for surface modification |
US5443458A (en) | 1992-12-22 | 1995-08-22 | Advanced Cardiovascular Systems, Inc. | Multilayered biodegradable stent and method of manufacture |
US5350800A (en) | 1993-01-19 | 1994-09-27 | Medtronic, Inc. | Method for improving the biocompatibility of solid surfaces |
US5788979A (en) | 1994-07-22 | 1998-08-04 | Inflow Dynamics Inc. | Biodegradable coating with inhibitory properties for application to biocompatible materials |
DE19506188C2 (en) * | 1995-02-22 | 2003-03-06 | Miladin Lazarov | Implant and its use |
US6231600B1 (en) | 1995-02-22 | 2001-05-15 | Scimed Life Systems, Inc. | Stents with hybrid coating for medical devices |
US6120536A (en) | 1995-04-19 | 2000-09-19 | Schneider (Usa) Inc. | Medical devices with long term non-thrombogenic coatings |
US6099562A (en) | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
DE69634013T2 (en) | 1995-05-26 | 2005-12-15 | SurModics, Inc., Eden Prairie | PROCESS AND IMPLANTABLE OBJECT FOR PROMOTING ENDOTHELIALIZATION |
US5714360A (en) | 1995-11-03 | 1998-02-03 | Bsi Corporation | Photoactivatable water soluble cross-linking agents containing an onium group |
US5980948A (en) | 1996-08-16 | 1999-11-09 | Osteotech, Inc. | Polyetherester copolymers as drug delivery matrices |
US5786022A (en) * | 1996-10-31 | 1998-07-28 | Ethicon, Inc. | Coating mixture for surgical articles |
WO1998036784A1 (en) | 1997-02-20 | 1998-08-27 | Cook Incorporated | Coated implantable medical device |
IL132120A0 (en) | 1997-04-03 | 2001-03-19 | Guilford Pharm Inc | Biodegradable terephthalate polyester-poly (phosphate) polymers compositions articles and methods for making and using the same |
US6273913B1 (en) | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
GB2325934A (en) | 1997-06-03 | 1998-12-09 | Polybiomed Ltd | Treating metal surfaces to enhance bio-compatibility and/or physical characteristics |
US6121027A (en) * | 1997-08-15 | 2000-09-19 | Surmodics, Inc. | Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups |
US20010029351A1 (en) | 1998-04-16 | 2001-10-11 | Robert Falotico | Drug combinations and delivery devices for the prevention and treatment of vascular disease |
US20020188037A1 (en) | 1999-04-15 | 2002-12-12 | Chudzik Stephen J. | Method and system for providing bioactive agent release coating |
EP1555036B1 (en) * | 1998-04-27 | 2010-05-05 | Surmodics Inc. | Bioactive agent release coating |
US6254634B1 (en) | 1998-06-10 | 2001-07-03 | Surmodics, Inc. | Coating compositions |
WO2000010622A1 (en) | 1998-08-20 | 2000-03-02 | Cook Incorporated | Coated implantable medical device |
NO984144L (en) | 1998-09-09 | 2000-03-10 | Carmeda Ab | Composition comprising heparin as a non-thrombogenic surface coating |
US6153212A (en) | 1998-10-02 | 2000-11-28 | Guilford Pharmaceuticals Inc. | Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles, and methods of using the same |
US6419709B1 (en) | 1998-10-02 | 2002-07-16 | Guilford Pharmaceuticals, Inc. | Biodegradable terephthalate polyester-poly(Phosphite) compositions, articles, and methods of using the same |
EP1168934B1 (en) | 1999-04-12 | 2008-02-13 | Cornell Research Foundation, Inc. | Hydrogel-forming system with hydrophobic and hydrophilic components |
US6656206B2 (en) | 1999-05-13 | 2003-12-02 | Cardia, Inc. | Occlusion device with non-thrombogenic properties |
US6759054B2 (en) | 1999-09-03 | 2004-07-06 | Advanced Cardiovascular Systems, Inc. | Ethylene vinyl alcohol composition and coating |
US20070032853A1 (en) * | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
US6713119B2 (en) | 1999-09-03 | 2004-03-30 | Advanced Cardiovascular Systems, Inc. | Biocompatible coating for a prosthesis and a method of forming the same |
EP1131167B1 (en) | 1999-09-22 | 2004-07-07 | SurModics, Inc. | Water-soluble coating agents bearing initiator groups and coating process |
GB9928071D0 (en) | 1999-11-29 | 2000-01-26 | Polybiomed Ltd | Blood compatible medical articles |
AU2599501A (en) | 1999-12-29 | 2001-07-09 | Advanced Cardiovascular Systems Inc. | Device and active component for inhibiting formation of thrombus-inflammatory cell matrix |
US6503538B1 (en) | 2000-08-30 | 2003-01-07 | Cornell Research Foundation, Inc. | Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
US6562136B1 (en) * | 2000-09-08 | 2003-05-13 | Surmodics, Inc. | Coating apparatus and method |
US7261735B2 (en) * | 2001-05-07 | 2007-08-28 | Cordis Corporation | Local drug delivery devices and methods for maintaining the drug coatings thereon |
US6509104B2 (en) | 2000-12-05 | 2003-01-21 | Michigan Biotechnology Institute | Antithrombogenic polymer coating |
US20020087123A1 (en) | 2001-01-02 | 2002-07-04 | Hossainy Syed F.A. | Adhesion of heparin-containing coatings to blood-contacting surfaces of medical devices |
US6630460B2 (en) | 2001-02-09 | 2003-10-07 | Medtronic, Inc. | Heparin compositions and methods of making and using the same |
US8182527B2 (en) | 2001-05-07 | 2012-05-22 | Cordis Corporation | Heparin barrier coating for controlled drug release |
AU2002316340B2 (en) | 2001-08-02 | 2006-09-07 | Cornell Research Foundation, Inc. | Biodegradable polyhydric alcohol esters |
US6669980B2 (en) | 2001-09-18 | 2003-12-30 | Scimed Life Systems, Inc. | Method for spray-coating medical devices |
US7195640B2 (en) * | 2001-09-25 | 2007-03-27 | Cordis Corporation | Coated medical devices for the treatment of vulnerable plaque |
CA2457564C (en) * | 2001-10-05 | 2009-04-07 | Surmodics, Inc. | Particle immobilized coatings and uses thereof |
DE50213462D1 (en) | 2001-10-15 | 2009-05-28 | Hemoteq Ag | COATING OF STENTS TO PREVENT RESTENOSIS |
US7348055B2 (en) | 2001-12-21 | 2008-03-25 | Surmodics, Inc. | Reagent and method for providing coatings on surfaces |
US20030161938A1 (en) | 2002-02-22 | 2003-08-28 | Bo Johnson | Composition and method for coating medical devices |
ATE459380T1 (en) | 2002-08-13 | 2010-03-15 | Medtronic Inc | DOSAGE SYSTEMS OF ACTIVE INGREDIENTS WITH POLY(ETHYLENE-CO(METH)ACRYLATES, MEDICAL DEVICE AND METHOD |
US7232573B1 (en) * | 2002-09-26 | 2007-06-19 | Advanced Cardiovascular Systems, Inc. | Stent coatings containing self-assembled monolayers |
US6702850B1 (en) * | 2002-09-30 | 2004-03-09 | Mediplex Corporation Korea | Multi-coated drug-eluting stent for antithrombosis and antirestenosis |
CA2519503C (en) * | 2003-02-28 | 2015-04-28 | Biointeractions Ltd. | Drug delivery from a polymer coating on a medical device |
US7279174B2 (en) * | 2003-05-08 | 2007-10-09 | Advanced Cardiovascular Systems, Inc. | Stent coatings comprising hydrophilic additives |
US7329413B1 (en) * | 2003-11-06 | 2008-02-12 | Advanced Cardiovascular Systems, Inc. | Coatings for drug delivery devices having gradient of hydration and methods for fabricating thereof |
WO2005097222A1 (en) | 2004-03-26 | 2005-10-20 | Surmodics, Inc. | Process and systems for biocompatible surfaces |
-
2005
- 2005-03-25 US US11/090,655 patent/US7550444B2/en active Active
- 2005-03-25 JP JP2007505198A patent/JP2007530169A/en active Pending
- 2005-03-25 WO PCT/US2005/009908 patent/WO2005097223A1/en active Application Filing
- 2005-03-25 EP EP05729951A patent/EP1732619A1/en not_active Withdrawn
- 2005-03-25 EP EP10185675A patent/EP2329852A1/en not_active Withdrawn
- 2005-03-25 CA CA2560507A patent/CA2560507C/en not_active Expired - Fee Related
-
2006
- 2006-05-25 US US11/440,524 patent/US20060216324A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2007530169A (en) | 2007-11-01 |
CA2560507C (en) | 2011-08-16 |
US20050244453A1 (en) | 2005-11-03 |
EP1732619A1 (en) | 2006-12-20 |
EP2329852A1 (en) | 2011-06-08 |
US7550444B2 (en) | 2009-06-23 |
US20060216324A1 (en) | 2006-09-28 |
WO2005097223A1 (en) | 2005-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2560507A1 (en) | Composition and method for preparing biocompatible surfaces | |
US10869902B2 (en) | Cured gel and method of making | |
CA2538669C (en) | Medicated stent having multi-layer polymer coating | |
US9682175B2 (en) | Coating material and medical device system including same | |
US7014913B2 (en) | Rate-reducing membrane for release of an agent | |
Kavanagh et al. | Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems | |
WO2005099786A1 (en) | Coating compositions for bioactive agents | |
JP2009160427A (en) | Stent with medicated multi-layer hybrid polymer coating | |
KR20150115746A (en) | Coating for substrate | |
ATE529068T1 (en) | MULTI-LAYER COATED STENT FOR THE CONTROLLED RELEASE OF ACTIVE SUBSTANCES AND METHOD FOR THE PRODUCTION THEREOF | |
JP4732346B2 (en) | Polymeric drug elution system for medical devices | |
EP2073860A1 (en) | Drug releasing coatings for medical devices | |
JP2010506666A5 (en) | ||
MXPA06009770A (en) | Biocompatible coating, method, and use of medical surfaces. | |
WO2005069966B1 (en) | Vascular grafts with amphiphilic block copolymer coatings | |
Obiweluozor et al. | Mussel-inspired elastic interpenetrated network hydrogel as an alternative for anti-thrombotic stent coating membrane | |
JP2008289853A (en) | Coating agent for medical equipment which has anti-thrombus conjugate | |
Sun et al. | Characterization of pH-induced changes in the morphology of polyelectrolyte multilayers assembled from poly (allylamine) and low molecular weight poly (acrylic acid) | |
Park et al. | Blood-compatible and biodegradable polymer-coated drug-eluting stent | |
WO2008027488A3 (en) | Absorbent articles comprising polyamine-coated superabsorbent polymers | |
Jariwala et al. | New generation sirolimus eluting PTCA angioplasty balloon catheter for restenosis therapy | |
US20220062015A1 (en) | Drug eluting device and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20130325 |